|
Name |
Pestaloficiol F
|
| Molecular Formula | C16H22O4 | |
| IUPAC Name* |
(1aS,2S,7bS)-2-hydroxy-6,6-dimethyl-7b-(3-methylbut-2-enyl)-1a,2,3,5-tetrahydrooxireno[2,3-h]chromen-4-one
|
|
| SMILES |
CC(=CC[C@@]12[C@@H](O1)[C@H](CC3=C2OC(CC3=O)(C)C)O)C
|
|
| InChI |
InChI=1S/C16H22O4/c1-9(2)5-6-16-13-10(7-11(17)14(16)20-16)12(18)8-15(3,4)19-13/h5,11,14,17H,6-8H2,1-4H3/t11-,14-,16+/m0/s1
|
|
| InChIKey |
DWRYREFBMYRRST-HZUKXOBISA-N
|
|
| Synonyms |
Pestaloficiol F; CHEMBL1078031; (1aS,2S,7bS)-2-hydroxy-6,6-dimethyl-7b-(3-methylbut-2-enyl)-1a,2,3,5-tetrahydrooxireno[2,3-h]chromen-4-one
|
|
| CAS | NA | |
| PubChem CID | 44254170 | |
| ChEMBL ID | CHEMBL1078031 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 278.34 | ALogp: | 1.3 |
| HBD: | 1 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 59.1 | Aromatic Rings: | 3 |
| Heavy Atoms: | 20 | QED Weighted: | 0.623 |
| Caco-2 Permeability: | -4.582 | MDCK Permeability: | 0.00002510 |
| Pgp-inhibitor: | 0.123 | Pgp-substrate: | 0.013 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.058 |
| 30% Bioavailability (F30%): | 0.347 |
| Blood-Brain-Barrier Penetration (BBB): | 0.773 | Plasma Protein Binding (PPB): | 81.12% |
| Volume Distribution (VD): | 1.388 | Fu: | 20.27% |
| CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.292 |
| CYP2C19-inhibitor: | 0.176 | CYP2C19-substrate: | 0.769 |
| CYP2C9-inhibitor: | 0.049 | CYP2C9-substrate: | 0.056 |
| CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.093 |
| CYP3A4-inhibitor: | 0.077 | CYP3A4-substrate: | 0.366 |
| Clearance (CL): | 15.998 | Half-life (T1/2): | 0.15 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.565 |
| Drug-inuced Liver Injury (DILI): | 0.234 | AMES Toxicity: | 0.091 |
| Rat Oral Acute Toxicity: | 0.959 | Maximum Recommended Daily Dose: | 0.078 |
| Skin Sensitization: | 0.541 | Carcinogencity: | 0.929 |
| Eye Corrosion: | 0.009 | Eye Irritation: | 0.099 |
| Respiratory Toxicity: | 0.964 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003273 | ![]() |
0.486 | D0W6DG | ![]() |
0.258 | ||
| ENC002614 | ![]() |
0.486 | D02JNM | ![]() |
0.214 | ||
| ENC002617 | ![]() |
0.392 | D0Y2YP | ![]() |
0.211 | ||
| ENC003629 | ![]() |
0.386 | D04SFH | ![]() |
0.208 | ||
| ENC002618 | ![]() |
0.382 | D09WYX | ![]() |
0.203 | ||
| ENC002505 | ![]() |
0.366 | D0W2EK | ![]() |
0.203 | ||
| ENC004323 | ![]() |
0.348 | D0H1QY | ![]() |
0.203 | ||
| ENC005804 | ![]() |
0.333 | D06IIB | ![]() |
0.200 | ||
| ENC003122 | ![]() |
0.319 | D03VFL | ![]() |
0.200 | ||
| ENC004147 | ![]() |
0.316 | D0Q6NZ | ![]() |
0.200 | ||